<DOC>
	<DOC>NCT01254799</DOC>
	<brief_summary>This study aims to test the effect of Doxycycline in treatment of uterine bleeding during the use of injectable contraception that contains one hormone "progesterone only".</brief_summary>
	<brief_title>Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>1. Women under DMPA contraception for at least one month. 2. Accept to participate in the trial after receiving adequate information about the trial including information that she is a part of randomization comprising the possibility of receiving new treatment for bleeding or inactive ingredients. 3. Women's ability to keep an accurate menstrual diary for the study. 1. Lactating women for the fear of the effect of tetracycline on the breastfed infant. 2. Patients with already diagnosed local gynecological abnormality. 3. Women receiving treatment for bleeding within the last one month.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>